Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2021-07-29 Regulatory Filings
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides detailed information on related party transactions and balances for the half year ended March 31, 2021. The content includes names of key managerial personnel, related parties, and transaction details such as sales, purchases, unsecured loans, remuneration, and sitting fees. The document is not a full financial report but a regulatory disclosure specific to related party transactions. This type of document fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not constitute an annual or interim financial report or other specific filing types.
2021-07-29 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended June 30, 2021. It is issued by the registrars and depository services agents certifying the details of securities dematerialized/rematerialized during the period have been furnished to stock exchanges. The document is a compliance certificate related to regulatory requirements rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS).
2021-07-21 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE and NSE) dated 09.07.2021, reporting the outcome of an adjourned Board meeting held on the same date. The key points approved at the meeting include the audited financial results for the quarter and year ended 31.03.2021 and the auditors' report along with a declaration as per SEBI regulations. The document includes detailed financial statements such as the Profit and Loss Statement for the quarter and year ended 31 March 2021, with standalone financials and various line items of revenue, expenses, and profit/loss figures. The presence of audited financial results and auditors' report for a full fiscal year indicates this is an annual financial report. The document is substantive and contains actual financial data, not merely an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K equivalent) filing rather than a simple announcement or regulatory filing. Hence, the classification is Annual Report (10-K). FY 2021
2021-07-09 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is extremely short (114 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-07-08 English
Trading Window
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text content. There is no financial data, report title, regulatory references, or any descriptive information. The document length is very short (279 characters) and does not contain any report or announcement details. Given the lack of content, this cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2021-07-01 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the adjournment of a Board meeting originally scheduled for 30.06.2021. The meeting was to consider audited financial results for the quarter and year ended 31.03.2021 but was postponed due to delays related to a demerger audit. The letter does not contain any financial data or results itself, nor does it present any report. It is an announcement about the postponement of a Board meeting and the delay in financial results publication. Therefore, it is not an Annual Report, Interim Report, Earnings Release, or any detailed financial or management report. It is also not a Board/Management Information announcement about changes in board or management personnel. The document is a regulatory announcement informing the stock exchanges about a procedural change (adjournment of a meeting). Given the short length (1371 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2021-07-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.